Literature DB >> 9712872

Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation.

M P Crump1, K Rajarathnam, K S Kim, I Clark-Lewis, B D Sykes.   

Abstract

The solution structure of the CCR3-specific chemokine, eotaxin, has been determined by NMR spectroscopy. The quaternary structure of eotaxin was investigated by ultracentrifugation and NMR, and it was found to be in equilibrium between monomer and dimer under a wide range of conditions. At pH </= 5 and low ionic strength, eotaxin was found to be predominantly a monomer. The three-dimensional structure of the eotaxin monomer solved at pH 5.0 revealed that it has a typical chemokine fold, which includes a 3-stranded beta-sheet and an overlying alpha-helix. Except for the N-terminal residues (residues 1-8), the core of the protein is well defined. The eotaxin structure is compared with the chemokines regulated upon activation, normal T-cell expressed and secreted (RANTES) and monocyte chemoattractant protein-1 (MCP-1); eotaxin binds only CC chemokine receptor CCR3, whereas RANTES binds many receptors including CCR3, and MCP-1 binds a distinct receptor, CCR2. The RMSD of the eotaxin ensemble of structures with the RANTES average minimized monomeric subunit is 5.52 +/- 0.87 A over all backbone atoms and 1.14 +/- 0.09 A over backbone atoms of residues 11-28 and 34-65. The most important difference between the structures is in the N-terminal residues that are unstructured in eotaxin but structured in RANTES and MCP-1. Several residues in the loop region of RANTES show similar packing in eotaxin (residues 11-17). As the N-terminal and loop regions have been shown to be critical for receptor binding and signaling, this structure will be useful for determining the basis for CCR3 selectivity of the eotaxin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712872     DOI: 10.1074/jbc.273.35.22471

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Ion mobility mass spectrometry coupled with rapid protein threading predictor structure prediction and collision-induced dissociation for probing chemokine conformation and stability.

Authors:  Milady R Niñonuevo; Julie A Leary
Journal:  Anal Chem       Date:  2012-03-16       Impact factor: 6.986

2.  The solution structure of the anti-HIV chemokine vMIP-II.

Authors:  A C Liwang; Z X Wang; Y Sun; S C Peiper; P J Liwang
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

Review 3.  Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity.

Authors:  Lavanya Rajagopalan; Krishna Rajarathnam
Journal:  Biosci Rep       Date:  2006-10       Impact factor: 3.840

4.  The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter.

Authors:  Ghazal Banisadr; Terra J Frederick; Caroline Freitag; Dongjun Ren; Hosung Jung; Stephen D Miller; Richard J Miller
Journal:  Neurobiol Dis       Date:  2011-06-06       Impact factor: 5.996

5.  Homology modeling and molecular dynamics simulations of lymphotactin.

Authors:  J Xiong; J Lubkowski; R Nussinov
Journal:  Protein Sci       Date:  2000-11       Impact factor: 6.725

6.  A targeted proteomic assay for the measurement of plasma proteoforms related to human aging phenotypes.

Authors:  Richard D Semba; Pingbo Zhang; Min Zhu; Elisa Fabbri; Marta Gonzalez-Freire; Ruin Moaddel; Minghui Geng-Spyropoulos; Luigi Ferrucci
Journal:  Proteomics       Date:  2017-08       Impact factor: 3.984

7.  Backbone dynamics of the human CC chemokine eotaxin: fast motions, slow motions, and implications for receptor binding.

Authors:  M P Crump; L Spyracopoulos; P Lavigne; K S Kim; I Clark-lewis; B D Sykes
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

8.  Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor.

Authors:  B T Seet; R Singh; C Paavola; E K Lau; T M Handel; G McFadden
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

9.  Monomeric solution structure of the prototypical 'C' chemokine lymphotactin.

Authors:  E S Kuloglu; D R McCaslin; M Kitabwalla; C D Pauza; J L Markley; B F Volkman
Journal:  Biochemistry       Date:  2001-10-23       Impact factor: 3.162

10.  Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.

Authors:  Amanda E I Proudfoot; Tracy M Handel; Zoë Johnson; Elaine K Lau; Patricia LiWang; Ian Clark-Lewis; Frédéric Borlat; Timothy N C Wells; Marie H Kosco-Vilbois
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.